{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:41:36Z","timestamp":1773412896189,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T00:00:00Z","timestamp":1552694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T00:00:00Z","timestamp":1552694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA159385"],"award-info":[{"award-number":["CA159385"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA104334"],"award-info":[{"award-number":["CA104334"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA75293"],"award-info":[{"award-number":["CA75293"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA48084"],"award-info":[{"award-number":["CA48084"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA104334-S1"],"award-info":[{"award-number":["CA104334-S1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001299","name":"Prevent Cancer Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100001299","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2019,6,15]]},"DOI":"10.1007\/s12672-019-00360-7","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T03:03:11Z","timestamp":1552705391000},"page":"77-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of Estrogen in Androgen-Induced Prostate Carcinogenesis in NBL Rats"],"prefix":"10.1007","volume":"10","author":[{"given":"Nur","family":"Ozten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Liehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Horton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ercole L.","family":"Cavalieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor G.","family":"Rogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0023-6975","authenticated-orcid":false,"given":"Maarten C.","family":"Bosland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,16]]},"reference":[{"key":"360_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/oxfordjournals.jncimonographs.a024244","volume":"27","author":"MC Bosland","year":"2000","unstructured":"Bosland MC (2000) The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 27:39\u201366","journal-title":"J Natl Cancer Inst Monogr"},{"key":"360_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/carcin\/21.3.427","volume":"21","author":"BE Henderson","year":"2000","unstructured":"Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21:427\u2013433","journal-title":"Carcinogenesis"},{"key":"360_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1210\/jc.2010-1865","volume":"96","author":"ST Page","year":"2011","unstructured":"Page ST, Lin DW, Mostaghel EA, Marck BT, Wright JL, Wu J, Amory JK, Nelson PS, Matsumoto AM (2011) Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial. J Clin Endocrinol Metab 96:430\u2013437","journal-title":"J Clin Endocrinol Metab"},{"key":"360_CR4","first-page":"113","volume":"23","author":"RL Noble","year":"1982","unstructured":"Noble RL (1982) Prostate carcinoma of the Nb rat in relation to hormones. Int Rev Exp Pathol 23:113\u2013159","journal-title":"Int Rev Exp Pathol"},{"key":"360_CR5","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1210\/en.2014-1688","volume":"155","author":"MC Bosland","year":"2014","unstructured":"Bosland MC (2014) Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology 155:4629\u20134633","journal-title":"Endocrinology"},{"key":"360_CR6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0022-5347(17)40078-4","volume":"143","author":"HB Carter","year":"1990","unstructured":"Carter HB, Piantadosi S, Isaacs JT (1990) Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 143:742\u2013746","journal-title":"J Urol"},{"key":"360_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/tam.5.2.98.102","volume":"5","author":"A Vermeulen","year":"2002","unstructured":"Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I (2002) Estradiol in elderly men. Aging Male 5:98\u2013102","journal-title":"Aging Male"},{"key":"360_CR8","first-page":"375","volume":"77","author":"M Krieg","year":"1993","unstructured":"Krieg M, Nass R, Tunn S (1993) Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 77:375\u2013381","journal-title":"J Clin Endocrinol Metab"},{"key":"360_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/sj.bjc.6690445","volume":"80","author":"NE Eaton","year":"1999","unstructured":"Eaton NE, Reeves GK, Appleby PN, Key TJ (1999) Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Br J Cancer 80:930\u2013934","journal-title":"Br J Cancer"},{"key":"360_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jnci\/djm323","volume":"100","author":"AW Roddam","year":"2008","unstructured":"Roddam AW, Allen NE, Appleby P, Key TJ (2008) Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100:170\u2013183","journal-title":"J Natl Cancer Inst"},{"key":"360_CR11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s10552-011-9787-7","volume":"22","author":"S Yao","year":"2011","unstructured":"Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, Tang L, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Thompson IM, Ambrosone CB, Hoque A (2011) Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control 22:1121\u20131131","journal-title":"Cancer Causes Control"},{"key":"360_CR12","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1210\/jc.2003-030933","volume":"89","author":"SJ Ellem","year":"2004","unstructured":"Ellem SJ, Schmitt JF, Pedersen JS, Frydenberg M, Risbridger GP (2004) Local aromatase expression in human prostate is altered in malignancy. J Clin Endocrinol Metab 89:2434\u20132441","journal-title":"J Clin Endocrinol Metab"},{"key":"360_CR13","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1158\/1055-9965.EPI-09-0496","volume":"18","author":"RC Travis","year":"2009","unstructured":"Travis RC, Schumacher F, Hirschhorn JN, Kraft P, Allen NE, Albanes D, Berglund G, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Calle EE, Chanock S, Dunning AM, Hayes R, Feigelson HS, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Kaaks R, Kolonel LN, Ma J, Rodriguez L, Riboli E, Stampfer M, Stram DO, Thun MJ, Tj\u00f8nneland A, Trichopoulos D, Vineis P, Virtamo J, Le Marchand L, Hunter DJ (2009) CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the breast and prostate Cancer cohort consortium. Cancer Epidemiol Biomark Prev 18:2734\u20132744","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"360_CR14","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/carcin\/16.6.1311","volume":"16","author":"MC Bosland","year":"1995","unstructured":"Bosland MC, Ford H, Horton L (1995) Induction at high incidence of ductal prostate adenocarcinomas in NBL\/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. Carcinogenesis 16:1311\u20131317","journal-title":"Carcinogenesis"},{"key":"360_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1158\/1940-6207.CAPR-09-0152","volume":"3","author":"N Ozten","year":"2010","unstructured":"Ozten N, Horton L, Lasano S, Bosland MC (2010) Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model. Cancer Prev Res (Phila) 3:371\u2013380","journal-title":"Cancer Prev Res (Phila)"},{"key":"360_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/oxfordjournals.jncimonographs.a024247","volume":"2000","author":"E Cavalieri","year":"2000","unstructured":"Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D (2000) Estrogens as endogenous genotoxic agents--DNA adducts and mutations. J Natl Cancer Inst Monogr 2000:75\u201393","journal-title":"J Natl Cancer Inst Monogr"},{"key":"360_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1021\/tx700191p","volume":"21","author":"JL Bolton","year":"2008","unstructured":"Bolton JL, Thatcher GR (2008) Potential mechanisms of estrogen quinone carcinogenesis. Chem Res Toxicol 21:93\u2013101","journal-title":"Chem Res Toxicol"},{"key":"360_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jsbmb.2006.06.019","volume":"101","author":"PC Mailander","year":"2006","unstructured":"Mailander PC, Meza JL, Higginbotham S, Chakravarti D (2006) Induction of a. T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats. J Steroid Biochem Mol Biol 101:204\u2013215","journal-title":"J Steroid Biochem Mol Biol"},{"key":"360_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/carcin\/bgg191","volume":"25","author":"K Li","year":"2004","unstructured":"Li K, Todorovic MR, Devanesan P, Higginbotham S, Kofeler H, Ramanathan R, Gross ML, Rogan EG, Cavalieri EL (2004) Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25:289\u2013297","journal-title":"Carcinogenesis"},{"key":"360_CR20","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/ijc.22399","volume":"120","author":"M Saeed","year":"2007","unstructured":"Saeed M, Rogan E, Fernandez SV, Sheriff F, Russo J, Cavalieri E (2007) Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Int J Cancer 120:1821\u20131824","journal-title":"Int J Cancer"},{"key":"360_CR21","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1021\/tx010158c","volume":"14","author":"F Zhang","year":"2001","unstructured":"Zhang F, Swanson SM, van Breemen RB, Liu X, Yang Y, Gu C, Bolton JL (2001) Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases. Chem Res Toxicol 14:1654\u20131659","journal-title":"Chem Res Toxicol"},{"key":"360_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/carcin\/23.2.329","volume":"23","author":"EL Cavalieri","year":"2002","unstructured":"Cavalieri EL, Devanesan P, Bosland MC, Badawi AF, Rogan EG (2002) Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer. Carcinogenesis 23:329\u2013333","journal-title":"Carcinogenesis"},{"key":"360_CR23","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/pros.20484","volume":"66","author":"Y Markushin","year":"2006","unstructured":"Markushin Y, Gaikwad N, Zhang H, Kapke P, Rogan EG, Cavalieri EL, Trock BJ, Pavlovich C, Jankowiak R (2006) Potential biomarker for early risk assessment of prostate cancer. Prostate 66:1565\u20131571","journal-title":"Prostate"},{"key":"360_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/pros.20850","volume":"69","author":"L Yang","year":"2009","unstructured":"Yang L, Gaikwad NW, Meza J, Cavalieri EL, Muti P, Trock B, Rogan EG (2009) Novel biomarkers for risk of prostate cancer: results from a case-control study. Prostate 69:41\u201348","journal-title":"Prostate"},{"key":"360_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2012.08.027","volume":"334","author":"MC Bosland","year":"2013","unstructured":"Bosland MC (2013) A perspective on the role of estrogen in hormone-induced prostate carcinogenesis. Cancer Lett 334:28\u201333","journal-title":"Cancer Lett"},{"key":"360_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/carcin\/16.4.951","volume":"16","author":"X Han","year":"1995","unstructured":"Han X, Liehr JG, Bosland MC (1995) Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL\/Cr rats treated with estradiol-17 beta and testosterone. Carcinogenesis 16:951\u2013954","journal-title":"Carcinogenesis"},{"key":"360_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/0041-008X(92)90200-C","volume":"112","author":"P Ofner","year":"1992","unstructured":"Ofner P, Bosland MC, Vena RL (1992) Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes. Toxicol Appl Pharmacol 112:300\u2013309","journal-title":"Toxicol Appl Pharmacol"},{"key":"360_CR28","first-page":"3282","volume":"58","author":"DL McCormick","year":"1998","unstructured":"McCormick DL, Rao KV, Dooley L, Steele VE, Lubet RA, Kelloff GJ, Bosland MC (1998) Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. Cancer Res 58:3282\u20133288","journal-title":"Cancer Res"},{"key":"360_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/1097-0045(20000701)44:2<144::AID-PROS7>3.0.CO;2-G","volume":"44","author":"TD Oberley","year":"2000","unstructured":"Oberley TD, Zhong W, Szweda LI, Oberley LW (2000) Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 44:144\u2013155","journal-title":"Prostate"},{"key":"360_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1021\/tx980041x","volume":"11","author":"T Hofer","year":"1998","unstructured":"Hofer T, M\u00f6ller L (1998) Reduction of oxidation during the preparation of DNA and analysis of 8-hydroxy-2\u2032-deoxyguanosine. Chem Res Toxicol 11:882\u2013887","journal-title":"Chem Res Toxicol"},{"key":"360_CR31","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0891-5849(01)00681-5","volume":"31","author":"X Huang","year":"2001","unstructured":"Huang X, Powell J, Mooney LA, Li C, Frenkel K (2001) Importance of complete DNA digestion in minimizing variability of 8-oxo-dG analyses. Free Radic Biol Med 31:1341\u20131351","journal-title":"Free Radic Biol Med"},{"key":"360_CR32","first-page":"205","volume":"10","author":"N Ohishi","year":"1985","unstructured":"Ohishi N, Ohkawa H, Miike A, Tatano T, Yagi K (1985) A new assay method for lipid peroxides using a methylene blue derivative. Biochem Int 10:205\u2013211","journal-title":"Biochem Int"},{"key":"360_CR33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0021-9258(17)42347-7","volume":"269","author":"MY Wang","year":"1994","unstructured":"Wang MY, Ohkawa H, Miike A, Tatano T, Yagi K (1994) Identification of fatty acid hydroperoxide cofactors in the cytochrome P450-mediated oxidation of estrogens to quinone metabolites. Role and balance of lipid peroxides during estrogen-induced carcinogenesis. J Biol Chem 269:284\u2013291","journal-title":"J Biol Chem"},{"key":"360_CR34","doi-asserted-by":"publisher","first-page":"6943","DOI":"10.1073\/pnas.81.22.6943","volume":"81","author":"RC Gupta","year":"1984","unstructured":"Gupta RC (1984) Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci U S A 81:6943\u20136947","journal-title":"Proc Natl Acad Sci U S A"},{"key":"360_CR35","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/carcin\/7.9.1543","volume":"7","author":"MV Reddy","year":"1986","unstructured":"Reddy MV, Randerath K (1986) Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7:1543\u20131551","journal-title":"Carcinogenesis"},{"key":"360_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0027-5107(87)90043-1","volume":"179","author":"MV Reddy","year":"1987","unstructured":"Reddy MV, Randerath K (1987) 32P-analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C. Mutat Res 179:75\u201388","journal-title":"Mutat Res"},{"key":"360_CR37","first-page":"278","volume":"23","author":"JG Liehr","year":"1983","unstructured":"Liehr JG (1983) 2-Fluoroestradiol. Separation of estrogenicity from carcinogenicity. Mol Pharmacol 23:278\u2013281","journal-title":"Mol Pharmacol"},{"key":"360_CR38","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1210\/endo.142.6.8079","volume":"142","author":"SJ McPherson","year":"2001","unstructured":"McPherson SJ, Wang H, Jones ME, Pedersen J, Iismaa JP, Wreford N, Simpson ER, Risbridger GP (2001) Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology 142:2458\u20132467","journal-title":"Endocrinology"},{"key":"360_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0002-9440(10)64736-0","volume":"156","author":"KA Fowler","year":"2000","unstructured":"Fowler KA, Gill K, Kirma N, Dillehay DL, Tekmal RR (2000) Overexpression of aromatase leads to development of testicular leydig cell tumors : an in vivo model for hormone-mediated TesticularCancer. Am J Pathol 156:347\u2013353","journal-title":"Am J Pathol"},{"key":"360_CR40","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1210\/endo.142.6.8211","volume":"142","author":"X Li","year":"2001","unstructured":"Li X, Nokkala E, Yan W, Streng T, Saarinen N, Warri A, Huhtaniemi A, Santti R, Makela S, Poutanen M (2001) Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 142:2435\u20132442","journal-title":"Endocrinology"},{"key":"360_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1043-2760(02)00575-1","volume":"13","author":"RA Jarred","year":"2002","unstructured":"Jarred RA, McPherson SJ, Bianco JJ, Couse JF, Korach KS, Risbridger GP (2002) Prostate phenotypes in estrogen-modulated transgenic mice. Trends Endocrinol Metab 13:163\u2013168","journal-title":"Trends Endocrinol Metab"},{"key":"360_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0002-9440(10)61676-8","volume":"159","author":"I Leav","year":"2001","unstructured":"Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM (2001) Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 159:79\u201392","journal-title":"Am J Pathol"},{"key":"360_CR43","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1210\/endo.139.1.5809","volume":"139","author":"KM Lau","year":"1998","unstructured":"Lau KM, Leav I, Ho SM (1998) Rat estrogen receptor-alpha and -beta, and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats. Endocrinology 139:424\u2013427","journal-title":"Endocrinology"},{"key":"360_CR44","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1210\/endo.143.6.8846","volume":"143","author":"CJ Thompson","year":"2002","unstructured":"Thompson CJ, Tam NN, Joyce JM, Leav I, Ho SM (2002) Gene expression profiling of testosterone and estradiol-17 beta-induced prostatic dysplasia in Noble rats and response to the antiestrogen ICI 182,780. Endocrinology 143:2093\u20132105","journal-title":"Endocrinology"},{"key":"360_CR45","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/carcin\/18.8.1505","volume":"18","author":"KE Lane","year":"1997","unstructured":"Lane KE, Leav I, Ziar J, Bridges RS, Rand WM, Ho SM (1997) Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine. Carcinogenesis 18:1505\u20131510","journal-title":"Carcinogenesis"},{"key":"360_CR46","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/ijc.22814","volume":"121","author":"RC Travis","year":"2007","unstructured":"Travis RC, Key TJ, Allen NE, Appleby PN, Roddam AW, Rinaldi S, Egevad L, Gann PH, Rohrmann S, Linseisen J, Pischon T, Boeing H, Johnsen NF, Tj\u00f8nneland A, Overvad K, Kiemeney L, Bueno-de-Mesquita HB, Bingham S, Khaw KT, Tumino R, Sieri S, Vineis P, Palli D, Quir\u00f3s JR, Ardanaz E, Chirlaque MD, Larra\u00f1aga N, Gonzalez C, Sanchez MJ, Trichopoulou A, Bikou C, Trichopoulos D, Stattin P, Jenab M, Ferrari P, Slimani N, Riboli E, Kaaks R (2007) Serum androgens and prostate cancer among 643 cases and 643 controls in the European prospective investigation into Cancer and nutrition. Int J Cancer 121:1331\u20131338","journal-title":"Int J Cancer"},{"key":"360_CR47","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/jnci\/88.16.1118","volume":"88","author":"PH Gann","year":"1996","unstructured":"Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ (1996) Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88:1118\u20131126","journal-title":"J Natl Cancer Inst"},{"key":"360_CR48","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.eururo.2018.07.024","volume":"74","author":"EL Watts","year":"2018","unstructured":"Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, M\u00e4nnist\u00f6 S, Metter EJ, Mikami K, Milne RL, Ozasa K, Platz EA, Quir\u00f3s JR, Rissanen H, Sawada N, Stampfer M, Stanczyk FZ, Stattin P, Tamakoshi A, Tangen CM, Thompson IM, Tsilidis KK, Tsugane S, Ursin G, Vatten L, Weiss NS, Yeap BB, Allen NE, Key TJ, Travis RC (2018) Low free testosterone and prostate Cancer risk: a collaborative analysis of 20 prospective studies. Eur Urol 74:585\u2013594","journal-title":"Eur Urol"},{"key":"360_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa030660","volume":"349","author":"IM Thompson","year":"2003","unstructured":"Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215\u2013224","journal-title":"N Engl J Med"},{"key":"360_CR50","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","volume":"362","author":"GL Andriole","year":"2010","unstructured":"Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS (2010) Effect of dutasteride on the risk of prostate cancer. N Engl J Med 362:1192\u20131202","journal-title":"N Engl J Med"},{"key":"360_CR51","first-page":"439","volume":"8","author":"WA Sakr","year":"1994","unstructured":"Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJ, Haas GP (1994) High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 8:439\u2013443","journal-title":"In Vivo"},{"key":"360_CR52","doi-asserted-by":"publisher","first-page":"16951","DOI":"10.18632\/oncotarget.24763","volume":"9","author":"F Bremmer","year":"2018","unstructured":"Bremmer F, Jarry H, Unterkircher V, Kaulfuss S, Burfeind P, Radzun HJ, Str\u00f6bel P, Thelen P (2018) Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer. Oncotarget 9:16951\u201316961","journal-title":"Oncotarget"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-019-00360-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-019-00360-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-019-00360-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T22:06:02Z","timestamp":1663106762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-019-00360-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,16]]},"references-count":52,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2019,6,15]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1007\/s12672-019-00360-7","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,16]]},"assertion":[{"value":"2 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experiments described in this paper were reviewed and approved by the NYU School of Medicine Institutional Animal Care and Use Committee and all applicable national and institutional guidelines for the care and use of animals were followed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}